raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:100019

Myelodysplastic neoplasm with increased blasts type 1

Synonyms: MDS-IB1 · RAEB-1 · Refractory anemia with excess blasts type 1

Type
Clinical subtype
Group
Subtype of disorder
Inheritance
Not applicable
Age of onset
Adult
Status
active

A severe type of RAEB characterized by cytopenias and the following hematological parameters: uni- or multilineage dysplasia, 5% to 9% blasts in bone marrow or 2% to 4% in peripheral blood, and no Auer rods (abnormal, needle-shaped or round inclusions in the cytoplasm of myeloblasts and promyelocytes). Median survival has been reported to be 18 months.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMyelodysplastic neoplasm with increased blasts type 1MDS-IB1 · RAEB-1 · Refractory anemia with excess blasts type 1
frTumeur myélodysplasique avec augmentation des blastes type 1AREB-1 · Anémie réfractaire avec excès de blastes type 1 · RAEB-1
deMyelodysplastische Neoplasie mit erhöhtem Blastenanteil Typ 1Anämie, refraktäre, mit Blastenexzess-1 · MDS-IB1 · RAEB-1
esNeoplasia mielodisplásica con aumento de blastos tipo 1Anemia refractaria con exceso de blastos tipo 1 · MDS-IB1 · RAEB-1 · Síndrome mielodisplásico con aumento de blastos tipo 1
itNeoplasia mielodisplastica con aumento dei blasti tipo 1Anemia refrattaria con eccesso di blasti tipo 1 · MDS-IB1 · RAEB-1
nlMyelodysplastisch neoplasma met overmaat aan blasten type 1MDS met overmaat aan blasten type 1 · MDS-IB1 · RAEB-1 · Refractaire anemie met exces van blasten type 1
ptNeoplasia mielodisplásica com excesso de blastos tipo 1Anemia refratária com excesso de blastos tipo 1 · MDS-IB1 · RAEB-1
plNowotwór mielodysplastyczny ze zwiększoną liczbą blastów typu 1RAEB-1
csRefrakterní anémie s nadbytkem blastů, typ 1RAEB-1
ukМієлодиспластичне новоутворення з підвищеною кількістю бластів, тип 1MDS-IB1 · RAEB-1 · Рефрактерна анемія з надлишком бластів, тип 1
zh难治性贫血伴母细胞过多1型RAEB-1
trTip 1 aşırı blastlı refrakter anemiRAEB-1

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10D46.2NTBTattributedvalidated
ICD-112A35NTBTindexvalidated
MONDO0015040Evalidated
UMLSC1318550Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
TET2Disease-causing somatic mutation(s) inAssessedHGNC:25941ENSG000001687696128394q24tet methylcytosine dioxygenase 219483684[PMID]_19557078[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card